Russian vaccine against coronavirus agreed to produce in South Korea

The Russian vaccine against the Sputnik V coronavirus has been agreed to be produced in South Korea.

It is noted that the Russian Direct Investment Fund and the Korean company GL Rapha announced an agreement on the production of more than 150 million doses of the vaccine in the country. It is known that production will begin in December 2020, and export supplies in January 2021.

Earlier it was reported that Turkey also wanted to produce “Sputnik V”. Ankara is interested in production “at the facilities of Turkish pharmaceutical manufacturers after carrying out toxicological studies provided for by local legislation.”

Prior to that, Venezuelan President Nicolas Maduro said that the tests of the Sputnik V purchased by his government are going “very well”. In addition, Venezuelan Vice President Dalsi Rodriguez announced that the country will begin production of Sputnik V on its territory.

To date, two vaccines against COVID-19 have been registered in Russia. The first drug to be registered was Sputnik V, developed by the Gamaleya Center. It went into production on August 15th. On October 14, President Vladimir Putin announced the registration of EpiVacCorona from the Vector Center. Citizens from the risk group and doctors will be the first to receive the vaccine.

Add comment